| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |